Jakob

Karma: 583

Research manager at ICFG.eu, board member at Langsikt.no, doing policy research to mitigate risks from biotechnology and AI. Ex-SecureBio manager, ex-McKinsey Global Institute fellow and founder of the McKinsey Effective Altruism community. Follow me on Twitter at @jgraabak

No, the EMH does not imply that markets have long AGI timelines

Jakob24 Apr 2023 8:27 UTC

83 points

21 comments8 min readEA link

Visualizations of the significance—persistence—contingency framework

Jakob2 Sep 2022 18:22 UTC

27 points

0 comments6 min readEA link

Is GiveWell underestimating the health value of lead eradication?

Jakob21 Aug 2022 15:13 UTC

33 points

7 comments4 min readEA link

The 3rd wave of EA is coming—what does it mean for you?

Jakob19 Aug 2022 13:47 UTC

44 points

4 comments5 min readEA link

Exit opportunities after management consulting

Vaidehi Agarwalla16 Aug 2021 10:54 UTC

32 points

6 comments6 min readEA link

Why scale is overrated: The case for increasing EA policy efforts in smaller countries

Philip Hall Andersen15 Aug 2021 17:48 UTC

74 points

11 comments30 min readEA link

Maximizing impact during consulting: building career capital, direct work and more.

Vaidehi Agarwalla13 Aug 2021 13:59 UTC

21 points

2 comments25 min readEA link

Considerations and advice on entering management consulting

Vaidehi Agarwalla11 Aug 2021 13:06 UTC

50 points

9 comments15 min readEA link

Objectives of longtermist policy making

Henrik Øberg Myhre10 Feb 2021 18:26 UTC

54 points

7 comments22 min readEA link